Coronavirus (COVID-19)—new life-saving treatment for NHS patients

Coronavirus (COVID-19)—new life-saving treatment for NHS patients

The Department of Health and Social Care has announced that patients across the UK who are admitted to intensive care units, as a result of coronavirus (COVID-19), will receive new life-saving treatments shown to reduce the time spent in hospital by up to ten days. This follows the publication of the REMAP-CAP clinical trial results, which have demonstrated that the drugs tocilizumab and sarilumab, typically used to treat rheumatoid arthritis, reduced the risk of death from coronavirus by 24%, when administered to patients within 24 hours of entering intensive care. Supplies of the drugs are already available in hospitals across the UK. The drugs have also been added to the government’s export restriction list, which aims to protect supply for UK patients.

NHS national medical director, Professor Stephen Powis has stated:

'The fact there is now another drug that can help to reduce mortality for patients with COVID-19 is hugely welcome news and another positive development in the continued fight against the virus.'

Source: NHS patients to receive life-saving COVID-19 treatments that could cut hospital time by 10 days

Related Articles:
Latest Articles: